{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T19:23:18Z","timestamp":1792783398307,"version":"4.5.0"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,11,9]],"date-time":"2024-11-09T00:00:00Z","timestamp":1731110400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2024,11,9]],"date-time":"2024-11-09T00:00:00Z","timestamp":1731110400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"name":"TheraCryf PLC"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Adv Ther"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1007\/s12325-024-03018-1","type":"journal-article","created":{"date-parts":[[2024,11,9]],"date-time":"2024-11-09T02:24:29Z","timestamp":1731119069000},"page":"216-232","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["A Phase 1 Randomized, Placebo-Controlled Study Evaluating the Safety, Tolerability, and Pharmacokinetics of Enteric-Coated Stabilized Sulforaphane (SFX-01) in Male Participants"],"prefix":"10.1007","volume":"42","clinical-trial-number":[{"clinical-trial-number":"isrctn9628565","registry":"10.18810\/isrctn"}],"author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7782-9891","authenticated-orcid":false,"given":"Glen","family":"Clack","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3213-9600","authenticated-orcid":false,"given":"Christopher","family":"Moore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-0939-1650","authenticated-orcid":false,"given":"Linette","family":"Ruston","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Wilson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annelize","family":"Koch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danielle","family":"Webb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-1983-6637","authenticated-orcid":false,"given":"Nicholas","family":"Mallard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,11,9]]},"reference":[{"issue":"19","key":"3018_CR1","doi-asserted-by":"publisher","first-page":"3593","DOI":"10.3390\/molecules24193593","volume":"24","author":"Y Yagishita","year":"2019","unstructured":"Yagishita Y, Fahey JW, Dinkova-Kostova AT, Kensler TW. Broccoli or sulforaphane: is it the source or dose that matters? Molecules. 2019;24(19):3593.","journal-title":"Molecules"},{"issue":"2","key":"3018_CR2","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1089\/jmf.2018.0024","volume":"22","author":"A Vanduchova","year":"2019","unstructured":"Vanduchova A, Anzenbacher P, Anzenbacherova E. Isothiocyanate from broccoli, sulforaphane, and its properties. J Med Food. 2019;22(2):121\u20136.","journal-title":"J Med Food"},{"key":"3018_CR3","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1007\/128_2012_339","volume":"329","author":"TW Kensler","year":"2013","unstructured":"Kensler TW, Egner PA, Agyeman AS, Visvanathan K, Groopman JD, Chen JG, et al. Keap1-nrf2 signaling: a target for cancer prevention by sulforaphane. Top Curr Chem. 2013;329:163\u201377.","journal-title":"Top Curr Chem"},{"issue":"16","key":"3018_CR4","doi-asserted-by":"publisher","first-page":"1382","DOI":"10.1089\/ars.2014.6097","volume":"22","author":"SM Tortorella","year":"2015","unstructured":"Tortorella SM, Royce SG, Licciardi PV, Karagiannis TC. Dietary sulforaphane in cancer chemoprevention: the role of epigenetic regulation and HDAC inhibition. Antioxid Redox Signal. 2015;22(16):1382\u2013424.","journal-title":"Antioxid Redox Signal"},{"issue":"1","key":"3018_CR5","doi-asserted-by":"publisher","first-page":"72","DOI":"10.3390\/ijms18010072","volume":"18","author":"Z Miao","year":"2017","unstructured":"Miao Z, Yu F, Ren Y, Yang J. d,l-Sulforaphane Induces ROS-dependent apoptosis in human gliomablastoma cells by inactivating STAT3 Signaling pathway. Int J Mol Sci. 2017;18(1):72.","journal-title":"Int J Mol Sci"},{"key":"3018_CR6","doi-asserted-by":"publisher","first-page":"9372182","DOI":"10.1155\/2019\/9372182","volume":"2019","author":"N Robledinos-Anton","year":"2019","unstructured":"Robledinos-Anton N, Fernandez-Gines R, Manda G, Cuadrado A. Activators and inhibitors of NRF2: a review of their potential for clinical development. Oxid Med Cell Longev. 2019;2019:9372182.","journal-title":"Oxid Med Cell Longev"},{"issue":"25","key":"3018_CR7","doi-asserted-by":"publisher","first-page":"4896","DOI":"10.1038\/s41388-020-1335-z","volume":"39","author":"BM Simoes","year":"2020","unstructured":"Simoes BM, Santiago-Gomez A, Chiodo C, Moreira T, Conole D, Lovell S, et al. Targeting STAT3 signaling using stabilised sulforaphane (SFX-01) inhibits endocrine resistant stem-like cells in ER-positive breast cancer. Oncogene. 2020;39(25):4896\u2013908.","journal-title":"Oncogene"},{"issue":"11","key":"3018_CR8","doi-asserted-by":"publisher","first-page":"1082","DOI":"10.3390\/ph14111082","volume":"14","author":"A Colapietro","year":"2021","unstructured":"Colapietro A, Rossetti A, Mancini A, Martellucci S, Ocone G, Pulcini F, et al. Multiple antitumor molecular mechanisms are activated by a fully synthetic and stabilized pharmaceutical product delivering the active compound sulforaphane (SFX-01) in preclinical model of human glioblastoma. Pharmaceuticals (Basel). 2021;14(11):1082.","journal-title":"Pharmaceuticals (Basel)"},{"issue":"3","key":"3018_CR9","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1530\/ERC-17-0483","volume":"25","author":"Y Zhou","year":"2018","unstructured":"Zhou Y, Yang G, Tian H, Hu Y, Wu S, Geng Y, et al. Sulforaphane metabolites cause apoptosis via microtubule disruption in cancer. Endocr Relat Cancer. 2018;25(3):255\u201368.","journal-title":"Endocr Relat Cancer"},{"issue":"4","key":"3018_CR10","doi-asserted-by":"publisher","first-page":"106","DOI":"10.3390\/antiox8040106","volume":"8","author":"M Mitsiogianni","year":"2019","unstructured":"Mitsiogianni M, Koutsidis G, Mavroudis N, Trafalis DT, Botaitis S, Franco R, et al. The role of isothiocyanates as cancer chemo-preventive, chemo-therapeutic and anti-melanoma agents. Antioxidants (Basel). 2019;8(4):106.","journal-title":"Antioxidants (Basel)."},{"issue":"3","key":"3018_CR11","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1097\/00001813-200603000-00008","volume":"17","author":"L Tang","year":"2006","unstructured":"Tang L, Li G, Song L, Zhang Y. The principal urinary metabolites of dietary isothiocyanates, N-acetylcysteine conjugates, elicit the same anti-proliferative response as their parent compounds in human bladder cancer cells. Anticancer Drugs. 2006;17(3):297\u2013305.","journal-title":"Anticancer Drugs"},{"key":"3018_CR12","doi-asserted-by":"crossref","unstructured":"Fahey JW, Wade KL, Wehage SL, Holtzclaw WD, Liu H, Talalay P, et al. Stabilized sulforaphane for clinical use: phytochemical delivery efficiency. Mol Nutr Food Res. 2017;61(4).","DOI":"10.1002\/mnfr.201600766"},{"issue":"11","key":"3018_CR13","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2019.e02951","volume":"5","author":"V Zambrano","year":"2019","unstructured":"Zambrano V, Bustos R, Mahn A. Insights about stabilization of sulforaphane through microencapsulation. Heliyon. 2019;5(11): e02951.","journal-title":"Heliyon"},{"key":"3018_CR14","doi-asserted-by":"publisher","first-page":"2716870","DOI":"10.1155\/2019\/2716870","volume":"2019","author":"CA Houghton","year":"2019","unstructured":"Houghton CA. Sulforaphane: its \u201cComing of Age\" as a clinically relevant nutraceutical in the prevention and treatment of chronic disease. Oxid Med Cell Longev. 2019;2019:2716870.","journal-title":"Oxid Med Cell Longev"},{"key":"3018_CR15","unstructured":"Dagan, ID. Stabilized sulforaphane (World Intellectual Property Organization Publication Number WO\/2008\/091608). World Intellectual Property Organization. 2008. https:\/\/patentscope.wipo.int\/search\/en\/detail.jsf?docId=WO2008091608"},{"issue":"7","key":"3018_CR16","doi-asserted-by":"publisher","first-page":"1819","DOI":"10.1007\/s00216-015-8482-z","volume":"407","author":"S Platz","year":"2015","unstructured":"Platz S, Piberger AL, Budnowski J, Herz C, Schreiner M, Blaut M, et al. Bioavailability and biotransformation of sulforaphane and erucin metabolites in different biological matrices determined by LC\u2013MS\u2013MS. Anal Bioanal Chem. 2015;407(7):1819\u201329.","journal-title":"Anal Bioanal Chem"},{"issue":"12","key":"3018_CR17","doi-asserted-by":"publisher","first-page":"3171","DOI":"10.1007\/s11095-011-0500-z","volume":"28","author":"JD Clarke","year":"2011","unstructured":"Clarke JD, Hsu A, Williams DE, Dashwood RH, Stevens JF, Yamamoto M, et al. Metabolism and tissue distribution of sulforaphane in Nrf2 knockout and wild-type mice. Pharm Res. 2011;28(12):3171\u20139.","journal-title":"Pharm Res"},{"issue":"5","key":"3018_CR18","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1016\/j.phrs.2011.07.005","volume":"64","author":"JD Clarke","year":"2011","unstructured":"Clarke JD, Hsu A, Riedl K, Bella D, Schwartz SJ, Stevens JF, et al. Bioavailability and inter-conversion of sulforaphane and erucin in human subjects consuming broccoli sprouts or broccoli supplement in a cross-over study design. Pharmacol Res. 2011;64(5):456\u201363.","journal-title":"Pharmacol Res"},{"key":"3018_CR19","doi-asserted-by":"crossref","unstructured":"Bouranis JA, Beaver LM, Ho E. Metabolic fate of dietary glucosinolates and their metabolites: a role for the microbiome. Front Nutr. 2021;8:748433.","DOI":"10.3389\/fnut.2021.748433"},{"key":"3018_CR20","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdz242.036","volume":"30","author":"SJ Howell","year":"2019","unstructured":"Howell SJ, Campone M, Cort\u00e9s J, Duhoux FP, Ross S, Morris T, et al. 341P - Final results of the STEM trial: SFX-01 in the treatment and evaluation of ER+ Her2- metastatic breast cancer (mBC). Ann Oncol. 2019;30: v122.","journal-title":"Ann Oncol"},{"key":"3018_CR21","doi-asserted-by":"crossref","unstructured":"Leung E, Wright E, Baguley BC. Effect of SFX-01 on proliferation of human glioblastoma cell lines. bioRxiv. 2021:2021.09.14.459936.","DOI":"10.1101\/2021.09.14.459936"},{"key":"3018_CR22","doi-asserted-by":"crossref","unstructured":"Long MB, Abo-Leyah H, Giam YH, Vadiveloo T, Hull RC, Keir HR, et al. SFX-01 in hospitalised patients with community-acquired pneumonia during the COVID-19 pandemic: a double-blind, randomised, placebo-controlled trial. ERJ Open Res. 2024;10(2):00917\u20132023.","DOI":"10.1183\/23120541.00917-2023"},{"issue":"43","key":"3018_CR23","doi-asserted-by":"publisher","first-page":"15550","DOI":"10.1073\/pnas.1416940111","volume":"111","author":"K Singh","year":"2014","unstructured":"Singh K, Connors SL, Macklin EA, Smith KD, Fahey JW, Talalay P, et al. Sulforaphane treatment of autism spectrum disorder (ASD). Proc Natl Acad Sci USA. 2014;111(43):15550\u20135.","journal-title":"Proc Natl Acad Sci USA"},{"key":"3018_CR24","doi-asserted-by":"crossref","unstructured":"Magner M, Thorov\u00e1 K, \u017dupov\u00e1 V, Hou\u0161ka M, \u0160vandov\u00e1 I, Novotn\u00e1 P, et al. Sulforaphane treatment in children with autism: a prospective randomized double-blind study. Nutrients. 2023;15(3):718.","DOI":"10.3390\/nu15030718"},{"issue":"1","key":"3018_CR25","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/s40360-018-0204-7","volume":"19","author":"SY Kyung","year":"2018","unstructured":"Kyung SY, Kim DY, Yoon JY, Son ES, Kim YJ, Park JW, et al. Sulforaphane attenuates pulmonary fibrosis by inhibiting the epithelial-mesenchymal transition. BMC Pharmacol Toxicol. 2018;19(1):13.","journal-title":"BMC Pharmacol Toxicol"},{"key":"3018_CR26","doi-asserted-by":"publisher","DOI":"10.1016\/j.physbeh.2022.114038","volume":"259","author":"S Ivan","year":"2023","unstructured":"Ivan S, Daniela O, Jaroslava BD. Sex differences matter: males and females are equal but not the same. Physiol Behav. 2023;259: 114038.","journal-title":"Physiol Behav"},{"issue":"2","key":"3018_CR27","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1073\/pnas.1321060111","volume":"111","author":"D Furman","year":"2014","unstructured":"Furman D, Hejblum BP, Simon N, Jojic V, Dekker CL, Thi\u00e9baut R, et al. Systems analysis of sex differences reveals an immunosuppressive role for testosterone in the response to influenza vaccination. Proc Natl Acad Sci USA. 2014;111(2):869\u201374.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"6","key":"3018_CR28","doi-asserted-by":"publisher","first-page":"C1095","DOI":"10.1152\/ajpcell.00091.2022","volume":"322","author":"H Islam","year":"2022","unstructured":"Islam H, Jackson GS, Yoon JSJ, Cabral-Santos C, Lira FS, Mui AL, et al. Sex differences in IL-10\u2019s anti-inflammatory function: greater STAT3 activation and stronger inhibition of TNF-\u03b1 production in male blood leukocytes ex vivo. Am J Physiol Cell Physiol. 2022;322(6):C1095\u2013104.","journal-title":"Am J Physiol Cell Physiol"},{"issue":"4","key":"3018_CR29","doi-asserted-by":"publisher","first-page":"829","DOI":"10.3390\/molecules25040829","volume":"25","author":"A Langston-Cox","year":"2020","unstructured":"Langston-Cox A, Anderson D, Creek DJ, Palmer K, Wallace EM, Marshall SA. Measuring sulforaphane and its metabolites in human plasma: a high throughput method. Molecules. 2020;25(4):829.","journal-title":"Molecules"},{"issue":"2","key":"3018_CR30","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1159\/000495274","volume":"51","author":"H-J Liu","year":"2018","unstructured":"Liu H-J, Wang L, Kang L, Du J, Li S, Cui H-X. Sulforaphane-N-acetyl-cysteine induces autophagy through activation of ERK1\/2 in U87MG and U373MG cells. Cell Physiol Biochem. 2018;51(2):528\u201342.","journal-title":"Cell Physiol Biochem"},{"issue":"5","key":"3018_CR31","doi-asserted-by":"publisher","first-page":"585","DOI":"10.3390\/nu10050585","volume":"10","author":"P Liu","year":"2018","unstructured":"Liu P, Wang W, Zhou Z, Smith AJO, Bowater RP, Wormstone IM, et al. Chemopreventive activities of sulforaphane and its metabolites in human hepatoma HepG2 cells. Nutrients. 2018;10(5):585.","journal-title":"Nutrients"},{"issue":"9","key":"3018_CR32","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1038\/s41419-020-03024-5","volume":"11","author":"Y Zhou","year":"2020","unstructured":"Zhou Y, Wang Y, Wu S, Yan Y, Hu Y, Zheng Z, et al. Sulforaphane-cysteine inhibited migration and invasion via enhancing mitophagosome fusion to lysosome in human glioblastoma cells. Cell Death Dis. 2020;11(9):819.","journal-title":"Cell Death Dis"},{"issue":"4","key":"3018_CR33","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1038\/s41419-019-1489-1","volume":"10","author":"Z Zheng","year":"2019","unstructured":"Zheng Z, Lin K, Hu Y, Zhou Y, Ding X, Wang Y, et al. Sulforaphane metabolites inhibit migration and invasion via microtubule-mediated Claudins dysfunction or inhibition of autolysosome formation in human non-small cell lung cancer cells. Cell Death Dis. 2019;10(4):259.","journal-title":"Cell Death Dis"},{"issue":"16","key":"3018_CR34","doi-asserted-by":"publisher","first-page":"5767","DOI":"10.1158\/0008-5472.CAN-04-1326","volume":"64","author":"MC Myzak","year":"2004","unstructured":"Myzak MC, Karplus PA, Chung FL, Dashwood RH. A novel mechanism of chemoprotection by sulforaphane: inhibition of histone deacetylase. Cancer Res. 2004;64(16):5767\u201374.","journal-title":"Cancer Res"},{"issue":"8","key":"3018_CR35","doi-asserted-by":"publisher","first-page":"1399","DOI":"10.1093\/carcin\/23.8.1399","volume":"23","author":"GP Basten","year":"2002","unstructured":"Basten GP, Bao Y, Williamson G. Sulforaphane and its glutathione conjugate but not sulforaphane nitrile induce UDP-glucuronosyl transferase (UGT1A1) and glutathione transferase (GSTA1) in cultured cells. Carcinogenesis. 2002;23(8):1399\u2013404.","journal-title":"Carcinogenesis"},{"issue":"11","key":"3018_CR36","doi-asserted-by":"publisher","first-page":"2231","DOI":"10.1002\/mnfr.201500457","volume":"59","author":"AL Piberger","year":"2015","unstructured":"Piberger AL, Keil C, Platz S, Rohn S, Hartwig A. Sulforaphane inhibits damage-induced poly (ADP-ribosyl)ation via direct interaction of its cellular metabolites with PARP-1. Mol Nutr Food Res. 2015;59(11):2231\u201342.","journal-title":"Mol Nutr Food Res"},{"key":"3018_CR37","unstructured":"Lorch U, Kata A, Gayed G, Taubel J. How adaptive study design can enrich an early phase multiple ascending dose study. In: American College of Clinical Pharmacology Annual Meeting. Atlanta, USA; 2014."},{"key":"3018_CR38","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/B978-0-12-824315-2.01189-1","volume-title":"Encyclopedia of toxicology","author":"SD Ray","year":"2024","unstructured":"Ray SD, Krmic M, Hussain A, Marvilli C, Fabian R, Niha A, et al. Toxicity of natural products. In: Wexler P, editor., et al., Encyclopedia of toxicology. 4th ed. Oxford: Academic Press; 2024. p. 257\u201382.","edition":"4"},{"issue":"2","key":"3018_CR39","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1007\/s10637-014-0189-z","volume":"33","author":"JJ Alumkal","year":"2015","unstructured":"Alumkal JJ, Slottke R, Schwartzman J, Cherala G, Munar M, Graff JN, et al. A phase II study of sulforaphane-rich broccoli sprout extracts in men with recurrent prostate cancer. Investig New Drugs. 2015;33(2):480\u20139.","journal-title":"Investig New Drugs"},{"issue":"1","key":"3018_CR40","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1080\/01635581.2019.1619783","volume":"72","author":"Z Zhang","year":"2020","unstructured":"Zhang Z, Garzotto M, Davis EW 2nd, Mori M, Stoller WA, Farris PE, et al. Sulforaphane bioavailability and chemopreventive activity in men presenting for biopsy of the prostate gland: a randomized controlled trial. Nutr Cancer. 2020;72(1):74\u201387.","journal-title":"Nutr Cancer"}],"container-title":["Advances in Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12325-024-03018-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12325-024-03018-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12325-024-03018-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,30]],"date-time":"2025-01-30T06:03:30Z","timestamp":1738217010000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12325-024-03018-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,9]]},"references-count":40,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,1]]}},"alternative-id":["3018"],"URL":"https:\/\/doi.org\/10.1007\/s12325-024-03018-1","relation":{},"ISSN":["0741-238X","1865-8652"],"issn-type":[{"value":"0741-238X","type":"print"},{"value":"1865-8652","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,9]]},"assertion":[{"value":"22 July 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 October 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 November 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Glen Clack is an employee of TheraCryf PLC; Glen Clack is also the managing director of Alise Onclogy Ltd which is a shareholder of TheraCryf PLC. Nicholas Mallard is an employee of TheraCryf PLC. Annelize Koch and Danielle Webb are employees of Simbec-Orion. Christopher Moore is an employee of Boyds (working for TheraCryf PLC). Linette Ruston is an employee of Seda Pharmaceutical Development Services (working for ThereCryf PLC). David Wilson is an employee of DJWstats consulting (working for TheraCryf PLC).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"All participants provided written informed consent to participate in the study. Participants were free to withdraw from the study at any time. The study protocol, together with participant information and consent forms, were reviewed and approved by Wales Research Ethics Committee 1. This study was conducted in accordance with the Declaration of Helsinki and complies with the International Council for Harmonisation Good Clinical Practice guidelines and applicable UK regulatory requirements.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}}]}}